H.R. 2214 · 119th Congress

DRUG Act

Introduced on Mar 18, 2025 by Mariannette Miller-Meeks (R-IA-1). 6 cosponsors, 4 of them from another party. Latest action (Mar 18, 2025): Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Stage
Introduced
Introduced
Mar 18, 2025
Cosponsors
6
4 from the other party
Policy area
Health
Open in the Congress explorerCongress.govAlert me

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. 2Reported by committee
  3. 3Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Official title

To improve services provided by pharmacy benefit managers.

Summary

The Congressional Research Service has not summarized this measure yet.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

Mariannette Miller-MeeksR-IA-1Sponsor

Democrats · 4

Republicans · 2

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

No recorded roll call on this measure: it moved by voice vote or unanimous consent, or has not reached the floor.

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. Mar 18, 2025Introduced in House
  2. Mar 18, 2025Introduced in House
  3. Mar 18, 2025 · HouseReferred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  4. Mar 18, 2025 · HouseReferred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  5. Mar 18, 2025 · HouseReferred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Who lobbied on it

Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.

  1. PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION15 reports
    $20M reported (all issues)
  2. PRIME THERAPEUTICS LLC12 reports
    $720K reported (all issues)
  3. PFIZER INC.7 reports
    $6.6M reported (all issues)Federal contractor: PFIZER INCAI match · 100%
  4. AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)6 reports
    $25.6M reported (all issues)
  5. CVS HEALTH6 reports
    $16.6M reported (all issues)
  6. EMD SERONO, INC.6 reports
    $4.7M reported (all issues)
  7. GSK (fka GLAXOSMITHKLINE INC.)6 reports
    $7.4M reported (all issues)
  8. JOHNSON & JOHNSON SERVICES, INC.6 reports
    $13.3M reported (all issues)
  9. NATIONAL COMMUNITY PHARMACISTS ASSOCIATION6 reports
    $1.9M reported (all issues)Federal contractor: NATIONAL COMMUNITY PHARMACISTS ASSOCIATIONAI match · 100%
  10. NOVARTIS CORPORATION6 reports
    $13.1M reported (all issues)Federal contractor: NOVARTIS PHARMACEUTICALS CORPORATION$36.2M in contracts, FY2026AI match · 100%
  11. PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA6 reports
    $57.5M reported (all issues)
  12. Pharmaceutical Research and Manufacturers of America (PhRMA)6 reports
    $240K reported (all issues)
  13. Southeast Georgia Hospital System6 reports
    $120K reported (all issues)
  14. Patients Rising Now5 reports
    $30K reported (all issues)
  15. The Cigna Group and subsidiaries (Formerly Cigna Corporation5 reports
    $11.9M reported (all issues)
  16. AMGEN INC.4 reports
    $13.3M reported (all issues)Federal contractor: AMGEN INC.AI match · 99%
  17. ELEVANCE HEALTH, INC.4 reports
    $7.6M reported (all issues)
  18. Government Counsel, LLC (obo) Prime Therapeutics4 reports
    $40K reported (all issues)
  19. AMERICAN PHARMACIES, INC.3 reports
    $180K reported (all issues)
  20. TAKEDA PHARMACEUTICALS AMERICA, INC.3 reports
    $2.5M reported (all issues)Federal contractor: TAKEDA PHARMACEUTICALS AMERICA, INC.$1.6M in contracts, FY2026AI match · 100%
  21. Fresenius Kabi USA LLC1 report
    $340K reported (all issues)Federal contractor: FRESENIUS KABI USA, LLCAI match · 100%

Reports filed in 2025, 2026.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 9, 2026 · loaded Oct 9, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 9, 2026 · loaded Oct 9, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
  • Money and votes are shown side by side; neither explains the other.